Stereoselective Synthesis of 2,6-Disubstituted Piperidines
COMMUNICATION
Physical data for selected compounds:
Acknowledgements
(ꢀ)-(2R,4S,6R)-2-Methyl-6-vinylpiperidin-4-ol (9a): Rf =0.3 (CH2Cl2/
MeOH 4:1); colorless needles; m.p. 82–838C; [a]2D0 =ꢀ4.7 (c=0.34 in
acetone, >99% ee); 1H NMR (300 MHz, CDCl3): d=5.82 (ddd, J=17.1,
10.5, 6.6 Hz, 1H; =CH), 5.16 (ddd, J=17.3, 1.3, 1.3 Hz, 1H; =CHEHZ),
5.04 (ddd, J=10.4, 1.1, 1.1 Hz, 1H; =CHEHZ), 3.69 (dddd, J=11.1, 11.1,
4.6, 4.6 Hz, 1H; CHOH), 3.20–3.13 (m, 1H; 6-H), 2.80–2.69 (m, 1H; 2-
H), 2.11 (brs, 2H; NH, OH), 2.01–1.90 (m, 2H; 3-HaHb, 5-HaHb), 1.22–
0.99 (m, 2H; 3-HaHb, 5-HaHb), 1.13 ppm (d, J=6.2 Hz, 3H; CH3);
13C NMR (75 MHz, CDCl3): d=140.28 (d, =CH), 114.96 (t, =CH2), 68.99
(d, CHOH), 57.74 (d, C-6), 50.26 (d, C-2), 43.33, 41.16 (2t, C-3, C-5),
22.36 ppm (q, CH3); HRMS (EI+): m/z calcd for C8H15NO+: 141.1148;
found: 141.1142 [M]+.
This work was supported by the Studienstiftung des deutschen Volkes.
We thank Prof. Frank R. Stermitz (Colorado State University) for send-
ing us a sample of racemic 2, Dr. Frank Rominger (Universitꢁt Heidel-
berg) for the crystal structure analyses, and Prof. Dr. K. Ditrich (BASF
AG) for enantiomerically pure 1-arylethylamines.
Keywords: alkaloids · allylic amination · heterocycles ·
iridium · total synthesis
(+)-(2R,4S,6S)-2-Methyl-6-vinylpiperidin-4-ol (9b): Rf =0.3 (CH2Cl2/
MeOH 4:1); colorless solid, m.p. 38–408C; [a]2D0 =+69.2 (c=0.27 in ace-
tone, >99% ee); 1H NMR (500 MHz, CDCl3): d=5.97 (ddd, J=17.3,
10.8, 5.6 Hz, 1H; =CH), 5.13 (ddd, J=17.4, 1.4, 1.4 Hz, 1H; =CHEHZ),
5.12 (ddd, J=10.5, 1.4, 1.4 Hz, 1H; CH=CHEHZ), 3.84 (dddd, J=11.0,
11.0, 4.5, 4.5 Hz, 1H; CHOH), 3.80–3.76 (m, 1H; 6-H), 3.01–2.94 (m,
1H; 2-H), 2.05–1.98 (m, 3H; 5-HaHb, OH, NH), 1.95–1.91 (m, 1H; 3-
HaHb), 1.58 (ddd, J=12.4, 11.3, 5.5 Hz, 1H; 5-HaHb), 1.10–1.02 (m, 1H;
3-HaHb), 1.08 ppm (d, J=6.4 Hz, 3H; CH3); 13C NMR (125 MHz,
CDCl3): d=140.06 (d, =CH), 115.20 (t, =CH2), 65.52 (d, CHOH), 54.46
(d, C-6), 44.93 (d, C-2), 44.18 (t, C-3), 38.68 (t, C-5), 22.76 ppm (q, CH3);
HRMS (EI+): m/z calcd for C8H15NO+: 141.1148; found: 141.1167
[M]+.
[1] G. M. Strunz, J. A. Findlay in The Alkaloids, Vol. 26 (Ed.: A.
Brossi), Academic Press, New York, 1985, pp. 89–183.
[3] a) H. Yokoyama, H. Ejiri, M. Miyazawa, S. Yamaguchi, Y. Hirai,
wara, E. Nishino, I. Takagi, K. Maeda, K. Tadano, S. Ogawa, Tetra-
[4] Reviews: a) G. Helmchen, A. Dahnz, P. Dꢃbon, M. Schelwies, R.
Synlett 2005, 1641–1655.
[5] Sequential Ir-catalyzed inter- and intramolecular aminations of bi-
sallylic substrates only yield the trans-diastereomer with high selec-
tivity: C. Welter, A. Dahnz, B. Brunner, S. Streiff, P. Dꢃbon, G.
Ir- and Pd-catalyzed allylic substitutions see: C. Welter, O. Koch, G.
and co-workers reported a highly stereoselective Ir-catalyzed double
allylation of guanidines: H. Miyabe, K. Yoshida, V. K. Reddy, Y.
(+)-(2R,4S,6S)-2-Methyl-6-nonylpiperidin-4-ol [(+)-241D] (1): Colorless
needles, m.p. 108–1098C, [a]2D0 =+5.9 (c=0.65 in MeOH, >99% ee);
1H NMR (500 MHz, CDCl3): d=3.66 (dddd, J=11.0, 11.0, 4.6, 4.6 Hz,
1H; CHOH), 2.71 (dqd, J=11.1, 6.3, 2.3 Hz, 1H; 2-H), 2.56 (dddd, J=
11.0, 6.4, 6.4, 2.2 Hz, 1H; 6-H), 2.01–1.93 (m, 4H; 3-Heq, 5-Heq, NH,
OH), 1.49–1.37 (m, 2H; 1’-H), 1.36–1.21 (m, 14H; CH2(n-nonyl)), 1.14 (d,
J=6.4 Hz, 3H; CH3CHN), 1.05 (ddd, J=11.6, 11.6, 11.6 Hz, 1H; 3-Hax),
1.00 (ddd, J=11.5, 11.5, 11.5 Hz, 1H; 5-Hax), 0.88 ppm (t, J=7.0 Hz, 3H;
CH3CH2); 13C NMR (125 MHz, CDCl3): d=69.43 (d, CHOH), 55.02 (d,
C-6), 50.36 (d, C-2), 43.86 (t, C-3), 41.63 (t, C-5), 36.73 (t, C-1’), 32.04,
29.87, 29.71, 29.69, 29.46, 26.15 (6t, CH2(n-nonyl)), 22.81 (t, CH2CH3), 22.41
(q, CH3CHN), 14.26 ppm (q, CH3CH2); HRMS (FAB+): m/z calcd for
C15H32NO+: 242.2478; found: 242.2453 [M+H]+.
[6] R. A. Johnson, K. B. Sharpless, Catalytic Asymmetric Synthesis, 2nd
ed. (Ed.: I. Ojima), Wiley-VCH, Weinheim, 2000, pp. 231–280.
[7] S. Fçrster, G. Helmchen, Synlett 2008, 831–836.
353. b) Preparation of L2: K. Tissot-Croset, D. Polet, S. Gille, C.
Hawner, A. Alexakis, Synthesis 2004, 2586–2590.
[9] The enantiomer of amine 3 has previously been prepared by other
routes: a) T. Fujisawa, S. Odake, Y. Ogawa, J. Yasuda, Y. Morita, T.
[10] The enantiomer of this alcohol has been already described: a) A.
Rae, A. E. Aliev, J. E. Anderson, J. L. Castro, J. Ker, S. Parsons, M.
[11] The aldehyde ent-4 has been synthesized before: M. Alcꢄn, M.
Canas, A. Moyano, M. A. Pericꢅs, A. Riera, Tetrahedron Lett. 1994,
35, 1589–1592.
[13] The diastereoselectivity of the allylation was determined by GC
[HP-1 (cross-linked methylsilicon gum), 25 mꢆ0.2 mmꢆ0.33 mm,
1408C isothermal, injector temperature 2508C, detector temperature
(+)-(2R,4S,6R)-2-Methyl-6-nonylpiperidin-4-ol (12b): Colorless needles;
m.p. 898C; [a]2D0 =+10.0 (c=0.57 in MeOH, >99% ee); 1H NMR
(600 MHz, CDCl3): d=3.87 (dddd, J=10.7, 10.7, 4.5, 4.5 Hz, 1H;
CHOH), 3.13–3.10 (m, 1H; 6-H), 2.94–2.88 (m, 1H; 2-H), 1.97–1.93 (m,
1H; 3-HaHb), 1.88–1.84 (m, 1H; 5-HaHb), 1.82 (brs, 2H; NH, OH), 1.55–
1.45 (m, 1H; 1’-HaHb), 1.48 (ddd, J=11.9, 11.6, 5.2 Hz, 1H; 5-HaHb),
1.44–1.38 (m, 1H; 1’-HaHb), 1.30–1.22 (m, 14H; CH2(n-nonyl)), 1.08 (d, J=
6.3 Hz, 3H; CH3CHN), 1.03 (ddd, J=11.4, 11.4, 11.4 Hz, 1H; 3-HaHb),
0.87 ppm (t, J=7.0 Hz, 3H; CH3CH2); 13C NMR (150 MHz, CDCl3): d=
65.71 (d, CHOH), 52.50 (d, C-6), 44.27 (d, C-2), 44.16 (t, C-3), 38.65
(t, C-5), 32.44 (t, C-1’), 32.02, 29.76, 29.76, 29.71, 29.45, 27.16 (6t,
CH2(n-nonyl)), 22.91 (t, CH2CH3), 22.81 (q, CH3CHN), 14.25 ppm (q,
CH3CH2); HRMS (ESI+): m/z calcd for C15H32NO+: 242.2478; found:
242.2483 [M+H]+.
(+)-(2R,4S,6S)-2-Methyl-6-propylpiperidin-4-ol (2): Colorless polyhedra;
m.p. 94–958C; [a]2D0 =+8.8 (c=0.43 in MeOH, >99% ee); 1H NMR
(500 MHz, CDCl3): d=3.63 (dddd, J=11.0, 11.0, 4.6, 4.6 Hz, 1H;
CHOH), 2.68 (dqd, J=11.0, 6.3, 2.3 Hz, 1H; 2-H), 2.58–2.53 (m, 1H; 6-
H), 1.98–1.90 (m, 2H; 3-HaHb, 5-HaHb), 1.85 (brs, 2H; NH, OH), 1.43–
1.30 (m, 4H; CH2CH2), 1.11 (d, J=6.3 Hz, 3H; CH3CHN), 1.05–0.93 (m,
2H; 3-HaHb, 5-HaHb), 0.90 ppm (t, J=7.1 Hz, 3H; CH3CH2); 13C NMR
(75 MHz, CDCl3): d=69.34 (d, CHOH), 54.66 (d, C-6), 50.28 (d, C-2),
44.00 (t, C-3), 41.78 (t, C-5), 39.06 (t, CH2CH2CH3), 22.55 (q, CH3CHN),
19.29 (t, CH2CH3), 14.28 ppm (CH3CH2); HRMS (ESI+): m/z calcd for
C9H20NO+: 158.1539; found: 158.1539 [M+H]+.
2808C]: tRACHTNUTRGNENUG(anti-5)=17.6 min, tRAHCTUNGTRNEN(UGN syn-5)=19.0 min.
[14] The relative configuration was verified by X-ray crystal structure
analysis. Selected crystallographic data for 9a: colorless needles,
C8H15NO, M=141.21, dimensions 0.68ꢆ0.05ꢆ0.04 mm3, orthorom-
bic, space group P212121, Z=4, a=6.3274(5), b=8.7135(8), c=
Chem. Eur. J. 2009, 15, 2050 – 2054
ꢂ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2053